Often referred to as Warren Buffett of India, Rakesh Jhunjhunwala was one of India’s most successful investors. He started investing in 1985 with Rs 5,000 when BSE Index was at 150. Today, the 30-share benchmark is above 64,000. Rakesh Jhunjhunwala’s investing preferences included the right decision, investment in potential multibaggers, and portfolio changes as needed. Jhunjhunwala passed away on August 14, 2022, leaving behind a rich legacy.
Rakesh Jhunjhunwala is survived by his wife Rekha Jhunjhunwala, daughter Nishtha, and twin sons Aryaman and Aryaveer. While Nishtha, 19, is set to start her degree course in media and communication at Regent’s University, London, the 14-year-old twin boys are Class 9 students at Hill Spring International School. After Rakesh Jhunjhunwala passed away, ‘Forbes’ magazine declared Rekha as one of the richest women in the country with a net worth of $5.7 billion.
Rakesh Jhunjhunwala managed his asset management firm Rare Enterprises. 'Rare' was a nod to the blending of Rakesh and Rekha's names. According to reports, at the time of his death, the value of Rakesh Jhunjhunwala's portfolio of listed stocks stood at around Rs 31,833 crore. Take a look at how Rakesh Jhunjhunwala's portfolio has performed since his demise a year ago.
Continue viewing BT Visual Story
Catch the latest business news, share market updates, expert analysis and exclusives only on BTTV.in
According to Samco Securities, Rakesh Jhunjhunwala had invested in 32 stocks as on August 16, 2023. His portfolio included the highest stock holding in Titan, a watch and jewellery retail arm of the Tata Group, and significant investments in Star Health, Allied Insurance Company, and Metro Brands. Other notable investments were in Tata Motors, CRISIL.
As of August 16, 2022, Jhunjhunwala allocated Rs 11,189 crore in Titan stocks, Rs 7,091 crore in Star Health & Allied Insurance, and Rs 3,356 crore in Metro Brands. He held Rs 1,744 crore worth of Tata Motors shares and Rs 1,306 crore worth of CRISL shares. His other major shareholdings included Fortis Healthcare, Federal Bank, Canara Bank, IHCL.
As of August 2022, Rakesh Jhunjhunwala’s portfolio was diversified across 23 sectors. It included stocks from popular sectors like banks, pharmaceuticals, and lesser-known sectors like agrochemicals, edible oils, etc. His portfolio was bullish on the Jewellery sector with 34% weightage in shares of Titan Company, followed by Insurance (24.21%), Automobile (8.93%), and Banks (4.64%).
As per the latest corporate shareholdings filed, Rakesh Jhunjhunwala and Associates publicly hold 26 stocks with a net worth of over Rs. 38,004.0 crore as on August 14, 2023. As of the July quarter of FY24, the portfolio includes investments in various sectors, such as pharmaceutical (12%), private sector banks (8%), Finance-General (8%), Construction & Contracting- Real Estate (8%), and Misc (8%).
The top 10 contributors to Jhunjhunwala's portfolio are Titan Company (Rs 14,360 crore), Star Health and Allied Insurance Company (Rs 6,395 crore), Metro Brands (Rs 2,811 crore), Tata Motors (Rs 3,197 crore), Crisil (Rs 1,574 crore), Canara Bank, IHCL, Fortis Healthcare, NCC, Federal Bank, and Aptech.
Over the one year since his demise, Rakesh Jhunjhunwala's portfolio has experienced growth. As per data, the net worth of his portfolio surged nearly 20% to Rs 38,114 crore as of August 15, 2023, compared with Rs 31,833 crore on August 16, 2022.
Recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of Business Today. Investors should consult their financial advisors before taking any position.